The SYIS is a network of over 100 young immunologists working all over Switzerland, or with other strong ties to the country. Behind SYIS stands a team of highly motivated and enthusiastic active members working behind the scenes to bring you several events and news.
Co-Founder and Team Coordinator
Annika is a Mucosal Immunologist from Cologne, Germany. After her studies in Molecular Medicine in Freiburg, she moved to Switzerland in 2015 to join the laboratory of Wolf-Dietrich Hardt at ETH Zürich, for her PhD on mucosal immune responses to infections with the enteropathogen Salmonella Typhimurium. She received her doctorate in 2020 and now prepares to move on to Copenhagen for a Postdoc in the group of Kim B. Jensen to study how intestinal epithelial cells integrate inflammatory signals. Follow Annika on Twitter.
Co-Founder and Team Coordinator
Daniela is an immunologist from Italy, who obtained her PhD in Immunology at “Sapienza” University of Rome. She then moved to Switzerland as a postdoctoral fellow under the supervision of Prof. Sallusto first at the IRB in Bellinzona and later at the ETHZ. She has contributed to shed light on several aspects of human T cell biology in physiological and pathological conditions, including autoimmunity and immunodeficiency. After obtaining the SNSF PRIMA grant, in January 2020 she established the Human Neuroimmunology Group at the Institute of Microbiology, ETHZ. Follow Daniela on Twitter.
Communication Team Coordinator
Jorieke is an immunologist from the Netherlands, who obtained her PhD in 2020 from the Radboud University in Nijmegen, where she worked on designing 2D and 3D polymeric scaffolds to modulate the anti-cancer T cell response. She then moved to Switzerland to join the Programmable Biomaterials Laboratory at EPFL in Lausanne as a postdoctoral researcher on a Niels Stensen Fellowship. She currently focuses on engineering programmable DNA origami to study and control the spatial organization of immunomodulatory molecules. Follow Jorieke on Twitter.
Finances Team Coordinator
Pascal is a Tumor Immunologist from Lucerne, Switzerland. He got his BSc in Biomedical Sciences Fribourg, Switzerland, before moving to Bern. In Bern, he obtained his MSc and started a PhD in the lab of Prof. Dr. Adrian Ochsenbein. Pascal’s research focused on the role of IL-33/ST2 signaling in steady-state hematopoiesis and leukemia.
Pascal finished his PhD in May 2021, and is currently looking for a PostDoc position. Follow Pascal on Twitter.
Events Team Coordinator
Sinduya completed an Integrated Master’s degree (MSci) from King’s College London (UK), where she got her first taste of immunology through an industrial placement at UCB Pharma (UK). She started her doctoral thesis at the Institute of Experimental Immunology (University of Zurich, Switzerland) in 2018 under the supervision of Prof. Dr. Becher. Her PhD thesis work is focused on applying high dimensional cytometry techniques to query animal models of ageing, with a particular focus on myeloid and antigen presenting cells. Follow Sinduya on Twitter.
Flurina completed her studies in cellular biology at ETH Zürich. She then joined the lab of Prof. Dr. Michael Hottiger at the University of Zürich for her PhD thesis. Her research is focused on the effect of PARP inhibitors on the immune response and the functional analysis of PARP inhibitor target PARP1 in natural killer cells.
Originally from Romania, Ioana received her PhD from ETH Zurich in 2019 for her work on CD8 T cell receptor signaling and T cell exhaustion in chronic viral infection. She is currently working as a postdoc at ETH Zurich in the lab of Prof. Dr. Oxenius, where she focuses on CD8 T cell dysfunction. Follow Ioana on Twitter.
Niculò did his Bachelor's as well as part of his Master's Degree in Immunology and Microbiology at the ETH Zurich, Switzerland, before moving to the London School of Hygiene and Tropical Medicine to complete his Master Thesis in the field of malaria research. He then re-joined the laboratory of Prof. Annette Oxenius at the ETH Zurich to start his PhD focusing on asymmetric cell division and fate decision of CD8 T cells.
Julia completed her Master's degree in Immunology at the University of Zurich, working on the role of Innate lymphoid cells in cancer. Following an internship in Cancer Immunotherapy at Roche Schlieren, she started her doctoral thesis at the Institute of Physiology in 2020 under the supervision of Prof. Dr. Schneider. Her PhD projects focus on the role of cytokines in the alveolar niche under steady state and type II inflammation, with a specific focus on GM-CSF. Follow Julia on Twitter.
Juliana is an immunologist with experience on oral infections, and her main interests are mucosal immunology, especially at the oral and intestinal mucosa. She obtained her master's and PhD at the Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil with exchange periods at the National University of Rosario, Argentina, and at the University of Bern. Since 2017, she has been in Switzerland and has worked as postdoc at the Universities of Fribourg and Bern. Follow Juliana on Twitter.
Merve completed her master’s degree from Bilkent University, Turkey. She studied molecular mechanism for adenosine regulation of dendritic cells during her master’s. Afterwards, she joined Manfred Kopf’s lab at ETH Zurich in 2017, where she got experience in the field of lung immunology. Since January 2019, she is a PhD student at the University of Zurich, in the Roland Wenger lab. Her PhD thesis is focused on the effect of TGF-β on kidney proximal tubule metabolism and response to chronic renal injury.
Manal studied Biosciences and Biotechnology at the University of Camerino, Italy. She then completed her Master’s Degree in Integrated Immunology at the University of Erlangen-Nuremberg, Germany. After an internship at Karolinska Institutet, she became more curious about B cells and antibody subclasses. Now, she is pursuing her PhD at the Swiss Institute of Allergy and Asthma Research (SIAF) in the B Cell Immunology group. Her project is about Eosinophilic Esophagitis and aims to identify biomarkers to ease the diagnosis and monitoring of this disease.
Communication Team and Finances Team
Lester is a Scientific Collaborator in Adverse Drug Reactions – Analysis and Consulting GmbH, Bern, where he performs R&D projects for in vitro diagnostics of drug hypersensitivities and SARS-CoV-2-specific memory lymphocytes. Originally from Brunei Darussalam, Lester has over 10 years of intercultural communication from living abroad and studying/working in multi-national departments (Edinburgh - BSc (Honours); London - MSc DIC; Bern - PhD). Lester enjoys communicating science and mentoring future scientists. Follow Lester on Twitter.
Rachel earned her Bachelor’s and Master’s degree at the ETH in Zurich. After completing her thesis at Stanford, Rachel joined the Becher Group at the University of Zurich to pursue her PhD. There she is studying the role of cytokine signaling in various inflammatory diseases such as cancer.
Jackie is from France and is currently working as a PhD at ETH Zurich in the lab of Prof. Dr. Slack, where she focuses on antimicrobial resistance in Enterobacteriaceae. After completing her MSc degree at Bucknell University in Pennsylvania in the United States, she moved to Switzerland in 2019 to pursue her PhD in the Food Immunology group.
Reihane obtained her PhD degree from the medical faculty of Basel University and AO research Institute in Switzerland in July 2020. Since then, she has started her post-doctoral fellowship at University hospital of Zürich and SIAF in Davos. The main focus of her research is to investigate the immunological function of inflammatory skin diseases using high-multiplex imaging mass cytometry technology .
After her graduation as a Biotechnology Engineer in France, Maud worked for 3 years at the Roche Innovation Center Zurich in Cancer Immunotherapy Discovery. During this time, she also had the opportunity to co-lead an exploratory research project on the role of Dendritic cells in response to PD-L1 blockade. She is currently a PhD student at UZH in the Tugues Group and studies the immune cell interactions in the bone metastasis niche and characterizes liver metastasis from patients with colorectal cancer.